Newborn Screening Improving Children s Health

Similar documents
Most common metabolic disorders in childhood. Neonatal screening and diagnostic approach to the. Inborn errors of metabolism (IEM)

Newborn Screening: Blood Spot Disorders

Reliable. results. efficiently. for CH, galactosemia, CAH and CF screening

7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics

Disorders of Carbohydrates. Disorders of Galactose Metabolism Glycogen Storage Diseases Diabetes Mellitus

Attachment 1. Newborn Screening Program Description

Screening Newborns for Congenital Disorders

Analytes, instrumentation and software for neonatal screening. Complete solutions for screening newborns

Health and Wellness for all Arizonans. azdhs.gov

Disorder name: Congenital Adrenal Hyperplasia Acronym: CAH

SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY

Cost-Benefit Analysis of the Newborn Screening Program of the Philippines

Newborn Screening in Manitoba. Information for Health Care Providers

Symptoms Common symptoms that result from untreated biotinidase deficiency are listed in below:

Metabolic Disorders. Chapter Thomson - Wadsworth

A Guide for Prenatal Educators

Information leaflet for patients and families. Congenital Adrenal Hyperplasia (CAH)

Chapter 1: What is PKU?

Instructor s Manual Chapter 28 Endocrine Alterations. 1. Which of the following is an example of a negative feedback system?

Glycogen Storage Diseases (A group of genetic diseases)

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015

PKU PKU. Phenylketonuria TEMPLE. Information for families following Information for families after a positive newborn screening

COST-BENEFIT ANALYSIS OF NEWBORN SCREENING FOR GALACTOSEMIA IN THE PHILIPPINES

Saving Lives Through Newborn Screening: Making the Most of a Simple Blood Test

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.

Organic Acid Disorders

False-Positive Newborn Screen Using the Beutler Spot Assay for Galactosemia in Glucose-6-Phosphate Dehydrogenase Deficiency

Information for health professionals

Organic Acid Disorders

Fatty Acid Oxidation Disorders

Inborn Error Of Metabolism :

Hormones. Introduction to Endocrine Disorders. Hormone actions. Modulation of hormone levels. Modulation of hormone levels

TEMPLE MCADD. Tools Enabling Metabolic Parents LEarning ADAPTED BY THE DIETITIANS GROUP. British Inherited Metabolic Diseases Group

HEREDITARY METABOLIC DISEASES

Congenital Hypothyroidism

Congenital hypothyroidism and your child

Newborn Screening: Focus on Treatment

Information for health professionals

Screening for Phenylketonuria: A Literature Update for the U.S. Preventive Services Task Force

Newborn Bloodspot Screening Information for parents

Nutritional Management of Inborn Errors of Metabolism. Kay Davis, RD, CSP Esther Berenhaut, RD, CSP, CSR Aug 28, 2017

Newborn Bloodspot Screening Information for parents

DEFINITION: Masculinization of external genitalia in patients with normal 46XX karyotype.

Fatty Acid Oxidation Disorders

Human inherited diseases

Newborn Genetic Testing & Surveillance System

TEMPLE. Tools Enabling Metabolic Parents LEarning ADAPTED BY THE DIETITIANS GROUP. British Inherited Metabolic Diseases Group

THE KING AND THE SCRATCHED DIAMOND

GA-1. Glutaric Aciduria Type 1. TEMPLE Tools Enabling Metabolic Parents LEarning. Information for families after a positive newborn screening

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Organic Acid Disorders

Newborn Bloodspot Screening (NBS) Training for Health Visitors. December 2017

HYPOTHYROIDISM IN CHILDREN. IAP UG Teaching slides

Health Chapter ALABAMA STATE BOARD OF HEALTH ALABAMA DEPARTMENT OF PUBLIC HEALTH BUREAU OF FAMILY HEALTH SERVICES ADMINISTRATIVE CODE

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy

For Your Baby s Health Department of Health

WHAT IT MEANS or WHY YOU DO IT

MONGOLIA. The 1997 World Vision/Nutrition Research Center (WV/NRC) report showed that 5.8% of infants were born with a low birth weight (<2500 g).

MI Newborn Screening Program: An Overview of Follow-up & Case Management for Sickle Cell Conditions

So Much More Than The PKU Test

Pathophysiology of the Phenylketonuria

NEWBORN METABOLIC SCREEN, MINNESOTA

There are four different forms of Tarui disease, which are classed by their signs and symptoms and age of presentation.

An introduction to Phenylketonuria (PKU)

Amal Alamri. Phenylketonuria

Ambiguous genitalia (Disorders of sex development); is any case in which the external genitalia do not appear completely male or completely female.

After food is eaten, molecules in the digestive system called enzymes break proteins down into amino acids, fats into fatty acids, and

Let s Talk About Hormones!

Exam Key. NROSCI/BIOSC 1070 and MSNBIO 2070 Final Exam December 19, 2015 Total POINTS: % of grade in class

Organic Acid Disorders

GENOTYPE-PHENOTYPE CORRELATIONS IN GALACTOSEMIA COMPLICATIONS COMPLICATIONS COMPLICATIONS LONG-TERM CHRONIC COMPLICATIONS WITH NO CLEAR CAUSE

Chapter 18 Development. Sexual Differentiation

Testing for Genetic Disorders that Cause Brain Damage

Newborn screening project at departments of genetics and endocrinology SGPGIMS, Lucknow

The National Society for Phenylketonuria (United Kingdom) Ltd. The Child with PKU. Brenda Clark Professor Forester Cockburn Dr Linda Tyfield

Dr. Nermine Salah El-Din Prof of Pediatrics

Community Genetics. Hanan Hamamy Department of Genetic Medicine & Development Geneva University Hospital

IN SUMMARY HST 071 NORMAL & ABNORMAL SEXUAL DIFFERENTIATION Fetal Sex Differentiation Postnatal Diagnosis and Management of Intersex Abnormalities

Newborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet

Positive Newborn Screens: What do you do next?

Early Intervention: The Importance of Newborn Screening

PHENYLKETONURIA. Debbie Galo

Teen Pregnancy Prevention Series:

Metabolism of pentoses, glycogen, fructose and galactose. Jana Novotna

GUIDE TO NEWBORN SCREENING PROGRAMME

Amino Acid Disorders. Disorder name: Tyrosinemia, type 1. What is tyrosinemia 1? Genetic Fact Sheets for Parents

PRENATAL TREATMENT AND FERTILITY OF FEMALE PATIENTS WITH CONGENITAL ADRENAL HYPERPLASIA

Epidemiology of thyroid diseases

Hypoglycemia. When recognized early, hypoglycemia can be treated successfully.

GALACTOSEMIA. Incidence

Management. (By the World Health Organization according to the magnitude of the enzyme deficiency and the severity of hemolysis)

FLASH CARDS. Kalat s Book Chapter 11 Alphabetical

Metabolic diseases. Metabolism

Hyperandrogenism. Dr Jack Biko. MB. BCh (Wits), MMED O & G (Pret), FCOG (SA), Dip Advanced Endoscopic Surgery(Kiel, Germany)

Fatty Acid Oxidation Disorders Organic Acid Disorders

Hormones by location

TEMPLE. Tools Enabling Metabolic Parents LEarning ADAPTED BY THE DIETITIANS GROUP. British Inherited Metabolic Diseases Group

SUNY Downstate Medical Center -University Hospital of Brooklyn Network Department of Pathology Policy and Procedure

Bios 90/95. Jennifer Swann, PhD

Purpose. Newborn Screening- UC 260. What is NBS? What isn t NBS? History. History 2

Transcription:

Newborn Screening Improving Children s Health By Frans Sardi Satyawirawan* Ina Susianti Timan ** * Dep. Of Clinical Pathology, Cipto Mangunkusumo Hospital (1974-2006) **Dep. of Clinical Pathology, Cipto Mangunkusumo Hospital

New Born Screening Improving Children s Health Introduction - New born screening is an essential public health strategy - Enable early detection & management of several congenital metabolic disorders - Need good collaboration and responsibility in the system. Need dedicated Coordinator.

Newborn Screening Improving Children s Health Introduction Row data of Congenital Hypothyroidism (CH) in Indonesia, (2017) - Total newborn 5.000.000/year - Total babies screened 85.000 babies/year - % babies screened 1.7%/year - Incidence of CH 1 : 3000 - Total Cases 1600 babies/year - Total cases detected 28 babies/year

New Born Screening Improving Children s Health Introduction - If left untreated: Mental retardation or death - If early diagnosis and treatment: Result in normal growth and development of the affected individual. Treatment must be long life.

Before and After Screening

1.600 affected babies per year If not detected by Screening - disaster for the family. -Need life support for whole life ( around 65 years) by family and government. -Not productive (mental retardation= IQ about 80) -The cost of the patients are very high. If detected by Screening -The cost is much lower about 1/10 compared to the cost if the patients are not detected by screening.

IAEA contribution (1999-2011) IAEA (International Atomic Energy Agency) sponsored Newborn Screening for congenital hypothyroidism in East Asia states, including Indonesia.

Participants of IAEA Coordination Meeting for CH

The activities of IAEA Meeting with government to promote Newborn Screening in Indonesia. Moral support for starting Newborn Screening Technical guidance : workshops, symposia (every year for 10 years) Sponsor to get reagensia and a new instrument (Perkin Elmer)

The results of IAEA Contribution With the guidance of IAEA, Newborn Screening is starting in Bandung in 2000 and Jakarta in 2001 with government and IAEA support for reagensia & instrument. From 2001 2011 there are 57000 babies screened (6000 babies/year) in Jakarta and 18 cases found. Now (2017) there are 85.000 babies screened/year in Bandung and Jakarta that are funding by government.

Urgency Congenital Hypothyroidism Percentage of new born screened in: -Indonesia 1.7% -China 54% -Philippines 50% -Viet Nam 24% Indonesia Total cases: Total cases detected 1600 babies /year 28 babies/year

How to Screen? (Congenital Hypothyroidism) Preinstrumental phase - Sampling 3th-5th day of life Heel Prick Method Guthrie filter paper Transport and storage management of filter paper Instrumental Phase - Chemiluminescence (Fluorescence) method - Formerly Radioimmunoassay (RIA) method

Post Instrumental Phase - quick result - System for confirmation test repeat testing if: 18 22 mu/l - System for handling positive result (>22 mu/l) : Finding patient for consulting the pediatricians

Heel Prick Method

Fluoroskan Ascent

UK-Neqas Birmingham for TSH

Screening System

Congenital metabolic disorders & Incidence Congenital Hypothyroidism (CH). 1:3000 C ongenital Adrenal Hyperplasia (CAH). 1:10.000 15.000 Galactosemia (Gal). 1:18.000 180.000 Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency. 1:57 ( Philippines) Phenylketonuria (PKU). 1:15.000 25.000

Golden period Congenital Hypothyroidism Congenital Adrenal Hyperplasia Galactosemia G6PD Deficiency Phenylketonuria 28 days 7 days 7 days 21 day

Congenital Hypothyroidism Incidence: 1: 3000 Definition A condition characterized by absence or deficiency of thyroid SINCE birth. Causes - Defective development of thyroid gland - Abnormal location (ectopic) - Medication during pregnancy (iodine/anti thyroid) - Inheritage deficiency of thyroid hormon

Congenital Hypothyroidism Pathogenesis Absent or deficiency of thyroid hormone leads to irreversible mental retardation, impaired growth and organs function

Congenital Hypothyroidism Symptoms and Signs -Appear normal at birth until 3 months of life -Large fontanel, depressed nasal brigde, umbilical hernia, difficulty in suction when feeding, chocking etc. Golden Period Therapy before 4 weeks. The earlier the better.

Congenital Adrenal Hyperplasia (CAH) Incidence 1: 10.000-15.000 Definition Abnormal of adrenal gland secretion due to inherited enzyme disorder Causes Defect in gen coding Autosomal Recessive 90% cases are deficiency of 21-alfa-hydroxylase

Congenital Adrenal Hyperplasia Pathogenesis Deficiency enzyme 21-alfa-hydroxylase Increased testosteron Decreased aldosteron Decreased cortisol Symptoms and Signs Boy : masculine characteristic Girl : abnormal genitalia

Congenital Adrenal Hyperplasia Treatment - Hydrocortisone - Fluodrocortisone - operation for abnormal genital Golden Period - Within 7 day after birth

Galactosemia Incidence 1 : 18.000-180.000 Definition - Accumulation of galactose in the body due to disorder of carbohydrate metabolism. Causes - Mostly deficient of enzyme galactose-1- phosphate uridyl transferase (GALT) - Autosomal recessive

Galactosemia Pathogenesis Accumulated galactose will yield mental retardation and other complications Symptoms and signs - Appear several days after feeding breast milk or lactose milk formula: vomiting jaundice sepsis etc.

Galactosemia Therapy - Galactose free milk - Calcium supplementation Golden period - 7 days

G6PD Deficiency Incidence 1: 57 (Philippines) Definition Inherited hemolitic anemia due to deficiency of G6PD. Causes Defective genes in the X chromosome ( x- linked)

G6PD Deficiency Pathogenesis G6PD produces NADPH which is importance reductant to protect red blood cells. It prevent hemolysis of the red blood cells. G6PD Deficiency is trigger by some chemicals, foods, drugs and infections. In G6PD Defisiency, hemolysis leading to anemia and also hyper bilirubinemia (Kern icterus). Bilirubin is toxic to the brain and result in mental retardation

G6PD Defficiency Symptoms and signs Need trigger factors which lead to anemia hemolitic. Therapy - Avoid Fava bean, certain drugs and chemicals - Consult hematologist during crisis

Phenylketonuria (PKU) Incidence 1 : 15.000-25.000 Definition Inherited disorder of protein metabolism leading to high Phenylalanine in the blood. Causes Defective enzyme phenylalanine hydroxylase (PAH)

Phenylketonuria (PKU) Pathogenesis Break down of phenylalanine is blocked. Accumulation of phenylalanine will cause mental retardation and hypopigmentation. Simptoms and signs - Appear normal at birth - Musty body odor - Mental retardation

Phenylketonuria (PKU) Therapy - Diet phenylalanine (low protein food) - Special milk formula - breast feeding with certain guidance Golden period 21 days

Literatures 1. Manual of Operations of The National Comprehensive Newborn Screening System. Basilio JA,Estrada SC, Manalac EM, Padilla CD. Department of Health University of The Philippines Manila. National Institutes of Health. 2005. 2. Screening of Newborns for Congenital Hypothyroidism. Guidance for Developing Programmes. Therrell BL, Padilla CD. International Atomic Energy Agency, 2005. www-pub.iaea.org 3. Guidelines on the Prevention and Control of Congenital Hypothyroidism. Hannon H, Therrell BL. Division of Noncommunicable Diseases and Health Technology. Hereditary Disease Programme. 1991. www.who.int>iris>handle